“Report Highlights Market Development Propelled by Rising Cancer Charges and AI in Drug Discovery, with Breast Cancer Section Rising at 21.8% Due to Improved Screening and Early Prognosis”
BOSTON, Dec. 30, 2024 /PRNewswire/ — In accordance to the newest research from BCC Analysis, “Artificial Intelligence (AI) in Cancer” is estimated to improve from $2.2 billion in 2024 to attain $6.3 billion by 2029, at a compound annual development charge (CAGR) of 23.1% from 2024 by way of 2029.
The report explores AI expertise’s present and future potential in most cancers purposes, contemplating market drivers, restraints, and alternatives. It consists of projections by way of 2029 and examines the aggressive panorama. On this report, the market is segmented by software (screening, analysis, remedy, drug discovery, and so on.), most cancers kind (breast, lung, prostate, and so on.), and end-user (hospitals, diagnostic facilities, and so on.). It covers the areas of North America, Europe, Asia Pacific, and the Relaxation of the World. Firm profiles supply insights into their enterprise segments, financials, and up to date developments.
This report is well timed as a result of AI and ML have gotten essential in most cancers care, serving to to velocity up drug analysis and enhance diagnostic accuracy. It analyzes AI purposes in varied most cancers sorts and makes use of, similar to analysis and remedy, in addition to rising applied sciences and competitor actions.
The components driving the market embody:
AI in Drug Discovery and Improvement: AI considerably accelerates drug discovery by contemplating huge datasets to establish potential drug candidates extra shortly and precisely than conventional strategies. This leads to sooner improvement of efficient most cancers therapies, lowering time and prices.
Rising Incidence of Cancer: The rising quantity of most cancers instances globally drives the demand for superior diagnostic and therapy options. AI presents promising instruments to enhance early detection, customized therapy plans, and improve affected person outcomes, making it a vital expertise in addressing the rising most cancers burden.
Request a pattern copy of the global market for artificial intelligence (AI) in cancer report.
Report Synopsis
|
Report Metric |
Particulars |
|
Base 12 months thought-about |
2023 |
|
Forecast interval thought-about |
2024-2029 |
|
Base 12 months market measurement |
$1.8 billion |
|
Market measurement forecast |
$6.3 billion |
|
Development charge |
CAGR of 23.1% for the forecast interval of 2024-2029 |
|
Segments lined |
Cancer Kind, Software, Finish Person |
|
Areas lined |
North America, Europe, Asia-Pacific, Relaxation of the World |
|
International locations lined |
U.S., Canada, Mexico, Germany, France, U.Ok., Italy, Spain, Japan, India, South Korea, China, Australia, South America, Center East, Africa |
|
Market drivers |
• AI in Drug Discovery and Improvement • Rising Incidence of Cancer |
Fascinating info: